IL245317A0 - Ferric citrate for reducing cardiac failure in chronic kidney disease patients - Google Patents

Ferric citrate for reducing cardiac failure in chronic kidney disease patients

Info

Publication number
IL245317A0
IL245317A0 IL245317A IL24531716A IL245317A0 IL 245317 A0 IL245317 A0 IL 245317A0 IL 245317 A IL245317 A IL 245317A IL 24531716 A IL24531716 A IL 24531716A IL 245317 A0 IL245317 A0 IL 245317A0
Authority
IL
Israel
Prior art keywords
patients
heart failure
kidney disease
chronic kidney
ferric citrate
Prior art date
Application number
IL245317A
Other languages
English (en)
Hebrew (he)
Original Assignee
Keryx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals Inc filed Critical Keryx Biopharmaceuticals Inc
Publication of IL245317A0 publication Critical patent/IL245317A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL245317A 2013-11-04 2016-04-27 Ferric citrate for reducing cardiac failure in chronic kidney disease patients IL245317A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361899866P 2013-11-04 2013-11-04
PCT/US2014/063643 WO2015066593A1 (en) 2013-11-04 2014-11-03 Ferric citrate for reducing cardiac failure in chronic kidney disease patients

Publications (1)

Publication Number Publication Date
IL245317A0 true IL245317A0 (en) 2016-06-30

Family

ID=53005244

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245317A IL245317A0 (en) 2013-11-04 2016-04-27 Ferric citrate for reducing cardiac failure in chronic kidney disease patients

Country Status (15)

Country Link
US (3) US20160256486A1 (cg-RX-API-DMAC7.html)
EP (2) EP3747432A1 (cg-RX-API-DMAC7.html)
JP (3) JP2016535780A (cg-RX-API-DMAC7.html)
KR (1) KR102392441B1 (cg-RX-API-DMAC7.html)
CN (1) CN105873583A (cg-RX-API-DMAC7.html)
AU (1) AU2014341975A1 (cg-RX-API-DMAC7.html)
BR (1) BR112016009901A8 (cg-RX-API-DMAC7.html)
CA (1) CA2928200A1 (cg-RX-API-DMAC7.html)
EA (1) EA201690926A1 (cg-RX-API-DMAC7.html)
HK (1) HK1223031A1 (cg-RX-API-DMAC7.html)
IL (1) IL245317A0 (cg-RX-API-DMAC7.html)
MX (1) MX2016005734A (cg-RX-API-DMAC7.html)
SG (1) SG11201603091QA (cg-RX-API-DMAC7.html)
TW (2) TWI744215B (cg-RX-API-DMAC7.html)
WO (1) WO2015066593A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101665968B1 (ko) 2009-07-21 2016-10-13 케릭스 바이오파마슈티컬스 인코포레이티드 구연산철 투여형태
KR20210131457A (ko) 2013-06-05 2021-11-02 트리시다, 인크. 경구 투여를 위한 양성자-결합 중합체
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
ES2787218T3 (es) 2014-12-10 2020-10-15 Tricida Inc Polímeros de unión de protones para la administración oral
EP3452028A4 (en) 2016-05-06 2020-04-15 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS
SG11202003451UA (en) 2017-11-03 2020-05-28 Tricida Inc Compositions for and method of treating acid-base disorders
CA3117071A1 (en) 2018-10-29 2020-05-07 Pharmacosmos Holding A/S Treating iron deficiency with ferric carboxymaltose
CN114286682A (zh) * 2019-02-09 2022-04-05 法码科思莫斯控股有限公司 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁
CN117999069A (zh) * 2021-05-27 2024-05-07 凯克斯生物制药公司 柠檬酸铁的儿科调配物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE351366B (cg-RX-API-DMAC7.html) * 1965-06-08 1972-11-27 Teikoku Hormone Mfg Co Ltd
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
HUE025264T2 (en) * 2005-08-18 2016-02-29 Panion & Bf Biotech Inc Pharmaceutical-grade ferric citrate for medical use
HUE028029T2 (en) * 2006-01-30 2016-11-28 Panion & Bf Biotech Inc Method of treating chronic kidney disease
KR20080106506A (ko) * 2006-01-30 2008-12-08 글로보아시아 엘엘씨 만성 신장병의 치료 방법
KR101665968B1 (ko) 2009-07-21 2016-10-13 케릭스 바이오파마슈티컬스 인코포레이티드 구연산철 투여형태
WO2012006473A1 (en) * 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN113244209A (zh) * 2012-06-21 2021-08-13 凯克斯生物制药公司 柠檬酸铁在治疗慢性肾脏疾病患者中的应用

Also Published As

Publication number Publication date
CA2928200A1 (en) 2015-05-07
TW201609088A (zh) 2016-03-16
BR112016009901A8 (pt) 2020-04-14
EP3065734A4 (en) 2017-05-17
US20190307791A1 (en) 2019-10-10
JP2021073230A (ja) 2021-05-13
WO2015066593A1 (en) 2015-05-07
JP2019206562A (ja) 2019-12-05
CN105873583A (zh) 2016-08-17
JP2016535780A (ja) 2016-11-17
KR20160096597A (ko) 2016-08-16
EP3747432A1 (en) 2020-12-09
TWI744215B (zh) 2021-11-01
HK1223031A1 (zh) 2017-07-21
MX2016005734A (es) 2016-11-08
EA201690926A1 (ru) 2016-09-30
SG11201603091QA (en) 2016-05-30
TW202203910A (zh) 2022-02-01
EP3065734A1 (en) 2016-09-14
AU2014341975A1 (en) 2016-05-19
US20160256486A1 (en) 2016-09-08
JP6828100B2 (ja) 2021-02-10
US20250360167A1 (en) 2025-11-27
KR102392441B1 (ko) 2022-05-02

Similar Documents

Publication Publication Date Title
IL245317A0 (en) Ferric citrate for reducing cardiac failure in chronic kidney disease patients
CY2023027I2 (el) Ενωσεις πυριμιδινοδιονης εναντι καρδιακων παθησεων
NO2025048I1 (no) Ferric citrate coordination complex
EP3862044C0 (en) TWO-TIP HEMODIALYSIS CATHETER
DK3329951T3 (da) Intravaskulær blodpumpe
EP3362123A4 (en) MEDICAL LUER CONNECTION
BR302013004536S1 (pt) Configuração aplicada em curativo médico
EP2869866A4 (en) Catheter pump
EP2968894A4 (en) MEDICAL CONNECTOR
DK3127563T3 (da) Pumpe, især blodpumpe
BR302013004565S1 (pt) Configuração aplicada em curativo médico
EP3821931C0 (en) ORONASAL PATIENT INTERFACE
EP2922514A4 (en) BI-RADIAL PATIENT INTERFACE
BR302013006823S1 (pt) Configuração aplicada em curativo médico
BR302013006043S1 (pt) Configuração aplicada a uma cadeira
IL233089A0 (en) Methods for improving medical therapies
EP2913047A4 (en) Pulmonary disease-specific therapeutic agent
IL272222B (en) Electrocardiogram noise reduction
EP2974614A4 (en) MIDSOLE WITH A LAYER STRUCTURE
HRP20190122T1 (hr) Protutijelo protiv adrenomedulina (adm) ili fragment protutijela protiv adm ili okosnica ne-ig protiv adm, namijenjeni reguliranju ravnoteže tekućina kod pacijenta s kroničnom ili akutnom bolešću
EP2914112A4 (en) TREATMENT OF CANCER WITH POMALIDOMIDE ON A PERSON WITH AFFECTED KIDNEY FUNCTION
BR302012004766S1 (pt) Configuracao aplicada em injetor médico
BR112014009789A2 (pt) cisteamina no tratamento da doença fibrótica
LT2958624T (lt) Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas
JP2015535291A5 (cg-RX-API-DMAC7.html)